Prevalence of hepatitis B infection in long-stay mentally handicapped adults

European Journal of Epidemiology

Volumn 16, Issue 8, 2000, Pages 725-729

  Asensio, Francesca ^a   Bayas, José María ^b   Bertran, Maria Jesús ^b   Asenjo, Miguel Angel ^b  

^a HOSPITAL SANT JOAN DE DÉU   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Hepatitis B; Immunisation; Mentally handicapped

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B VACCINE;

ADULT; ARTICLE; DISEASE MARKER; HEPATITIS B; HEPATITIS B VIRUS; HOSPITALIZATION; HUMAN; INSTITUTIONAL CARE; MAJOR CLINICAL STUDY; MENTAL DEFICIENCY; PREVALENCE; SERODIAGNOSIS; VACCINATION;

ADULT; AGED; HEPATITIS B; HEPATITIS B VACCINES; HOSPITALS, PSYCHIATRIC; HUMANS; IMMUNIZATION PROGRAMS; INSTITUTIONALIZATION; MENTALLY DISABLED PERSONS; MIDDLE AGED; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES; SPAIN;

EID: 0034529664     PISSN: 03932990     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026793900057     Document Type: Article

References (52)

1. The epidemiology of serum hepatitis (SH) infections: A controlled study in two closed institutions
2. Different operating conditions affect risk of hepatitis B virus infection at two residential institutions for the mentally handicapped
3. Epidemiologia de la hepatitis B en Espana
4. Prevalence of hepatitis B markers in the population of Catalonia (Spain). Rationale for universal vaccination of adolescents
5. Prevalence of hepatitis B and C markers in the south-east of Spain: An unlinked community-based serosurvey of 2203 adults
6. Prevalencia de infeccion por el virus de la hepatitis Ben instituciones de deficientes mentales. Caracteristicas epidemiologicas en la provincia de Vizcaya
7. An institutional outbreak of hepatitis B related to a human biting carrier
8. Non-efficacy of low-dose intradermal vaccination against hepatitis B in Down's syndrome
9. A serum antigen (Australia antigen) in Down's syndrome, leukemia and hepatitis
10. Hepatitis B en una institucion abierta para retrasados mentales. Efecto inmunogenico de una vacuna recombinante antihepatitis B
11. Epidemiology of hepatitis B virus in non-institutionalized children and adolescents affected by handicap
12. Hepatitis B virus prevalence in two institutions for the mentally handicapped
13. Seroprevalence of hepatitis B and C in a Merseyside hospital for the mentally handicapped
14. The seroprevalence of hepatitis B and C in hospitalized Danish patients
15. Hepatitis B virus: A comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination
16. Universal vaccination against hepatitis B
17. Recommendations for protection against viral hepatitis
18. Hepatitis B virus transmission in a public school: Effects of mentally retarded HBs Ag carriers students
19. Decret 303/1985 de 31 d'octubre, sobre la regulacio de la prescripcio i dispensacio de la vacuna contra l'hepatitis B a les persones que pertenyen a determinats grups de risc elevat de patir la malatia
20. Ordre de 27 de novembre de 1989, per la qual s'estableixen els mecanismes de control i seguiment de l'us de la vacuna contra 1'hepatitis B, i es determinen els grups de risc elevat de patir la malatia
21. Prevalencia de la infeccion por el virus de la hepatitis B y por el agente delta en drogadictos
22. Hepatitis B among parenteral drug abusers-north Carolina
23. Hepatitis B markers in United States drug addicts with special emphasis on the delta hepatitis virus
24. Determinantes de la prevalencia de infeccion por virus B de la hepatitis en usuarios de drogas por via parenteral
25. Hepatitis B virus infection in prisons. A seroepidemiological survey in prisoners and attending staff
26. Hepatitis B y delta en reclusos jovenes
27. Hepatitis B vaccination in prisons. The Catalonian experience
28. Hepatitis B in a hospital for the mentally subnormal in southern England
29. Prevalencia de marcadores de infeccion por virus de la hepatitis A y B en pacientes y personal sanitario de una institacion para deficientes mentales
30. Prevalencia de marcadores de infeccion de los virus de la hepatitis B, Delta y HTLV-III en deficientes mentales
31. Distribucion del virus de la hepatitis B en un centro de disminuidos psiquicos de Madrid. Estimadores de riesgo
32. Prevalencia de marcadores serologicos para el virus de la inmunodeficiencia humana y el virus de la hepatitis B en un hospital psiquiatrico
33. Los deficientes mentales y la infeccion por el virus de la hepatitis B. Prevalencia en nuestro medio
34. Infecciones virales A, B, C y Den una institucion de deficientes mentales (DM)
35. Marcadores de la hepatitis B en tres centros abiertos para disminuidos psiquicos
36. Infeccion por virus de la hepatitis B y C en deficientes mentales
37. A 'new' antigen in leukemia sera
38. On the role of sexual behaviour in the spread of hepatitis B infection
39. Serologic responses in hepatitis B
40. Type B hepatitis after transfusion with blood donors containing anti-body to hepatitis B core antigen
41. Serologic marker of hepatitis B virus infection
42. Hepatitis B infection in a day school for mentally retarded students: Transmission from students to staff
43. Hepatitis B vaccination in the elderly
44. Immunogenicity of two recombinant hepatitis B vaccines in older individuals
45. Summary of clinical findings on Engerix-B, a genetically engineered yeast-derived hepatitis B vaccine
46. Immune responses to hepatitis B vaccine in the mentally retarded
47. Hepatitis B vaccination in Down's syndrome and other mentally retarded patients
48. Respuesta a la vacuna DNA recombinada antihepatitis B en los deficientes mentales con sindrome de Down. Estudio controlado
49. Progress on the control of hepatitis B infection through immunization
50. Protection against viral hepatitis
51. Hepatitis B in the non-residential mentally handicapped population
52. Immunogenicity of a recombinant DNA hepatitis B vaccine in institucionalized pacients with Down's syndrome